Prognostic value of FDG PET Imaging in patients with laryngeal cancer

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Kitajima, Kazuhiro ^a   Suenaga, Yuko ^a   Kanda, Tomonori ^b   Miyawaki, Daisuke ^a   Yoshida, Kenji ^a   Ejima, Yasuo ^a   Sasaki, Ryohei ^a   Komatsu, Hirokazu ^a   Saito, Miki ^a   Otsuki, Naoki ^a   Nibu, Ken Ichi ^a   Kiyota, Naomi ^a   Minamikawa, Tsutomu ^a   Sugimura, Kazuro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CERVICAL LYMPH NODE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISTANT METASTASIS FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PROGRESSION FREE SURVIVAL; RECEIVER OPERATING CHARACTERISTIC; DIAGNOSTIC USE; LARYNGEAL NEOPLASMS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; SCINTISCANNING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84901255240     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096999     Document Type: Article

References (13)

1. Haberkorn U, Strauss LG, Reisser C, Haag D, Dimitrakopoulou A, et al. (1991) Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med 32: 1548-1555.
2. Minn H, Clavo AC, Grenman R, Wahl RL (1995) In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 36: 252-258.
3. Zhang B, Li X, Lu X (2010) Standardized uptake value is of prognostic value for outcome in head and neck squamous cell carcinoma. Acta Otolaryngol 130: 756-762.
4. 18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a metaanalysis. J Cancer Res Clin Oncol 137: 1085-1093.
5. Demirci U, Coskun U, Akdemir UO, Benekli M, Kapucu O, et al. (2011) The nodal standard uptake value (SUV) as a prognostic factor in head and neck squamous cell cancer. Asian Pac J Cancer Prev 12: 1817-1820.
6. Inokuchi H, Kodaira T, Tachibana H, Nakamura T, Tomita N, et al. (2011) Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection. Int J Radiat Oncol Biol Phys 79: 747-755.
7. Kubicek GJ, Champ C, Fogh S, Wang F, Reddy E, et al. (2010) FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head Neck Oncol 2: 19-25.
8. Allal AS, Slosman DO, Kebdani T, Allaoua M, Lehmann W, et al. (2004) Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 59: 1295-1300.
9. Tang C, Murphy JD, Khong B, La TH, Kong C, et al. (2012) Validation that metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 83: 1514-1520.
10. Beaulieu S, Kinahan P, Tseng J, Dunnwald LK, Schubert EK, et al. (2003) SUV varies with time after injection (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences. J Nucl Med 4: 1044-1050.
11. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, et al. (1993) Influence of the blood glucose concentration on FEDG uptake in cancer - a PET study. J Nucl Med 34: 1-6.
12. Keyes JW (1995) SUV: standard uptake or silly useless value? J Nucl Med 36: 1836-1839.
13. Schöder H, Erdi YE, Chao K, Gonen M, Larson SM, et al. (2004) Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. J Nucl Med 45: 559-566.